UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS

普遍性和免疫稳态的调节

• 批准号: 8169756
• 负责人: AVERIL I MA
• 金额: $ 0.18万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-12 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8169756
• 关键词: Biochemical; Cells; Computer Retrieval of Information on Scientific Projects Database; Data; Disease; Enzymes; Eukaryotic Cell; Funding; Genetic; Grant; Homeostasis; Immune; Immune response; Inflammatory Response; Institution; Intestines; Link; Mediating; Modification; Mus; Myeloid Cells; Proteins; Receptor Signaling; Regulation; Research; Research Personnel; Resources; Signal Transduction; Signaling Protein; Source; TRAF6 gene; Testing; Toll-like receptors; United States National Institutes of Health; in vivo; insight; microbial; novel; pathogen; prevent; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Toll like receptors (TLRs) on eukaryotic cells mediate the recognition of microbial molecules and regulate host responses to microbial pathogens. Proper regulation of TLR signals not only restricts the intensity and duration of inflammatory responses, but may also maintain immune homeostasis in the intestine, where a plethora of microbial pathogens co-exist with host cells. Recent studies from our labs indicate that A20 is a novel protein that is required for terminating TLR induced signals on myeloid cells and for preventing excessive inflammatory responses in vivo. Our preliminary data suggest that A20 is essential for restricting TLR signals in vivo. Moreover, our findings suggest that A20 may be a novel enzyme that performs this critical function by directly modulating the ubiquitylation status of TLR signaling proteins such as TRAF6. These modifications may cause both de-activation and degradation of TLR signaling proteins. These exciting preliminary findings provide us with unique opportunities to test our central hypothesis that A20 regulates ubiquitylation of signaling proteins, TLR signals, and immune homeostasis. This application represents a synergistic effort between the genetic and cellular expertises of the Ma lab and the biochemical expertise of the Pickart lab to determine: (i) whether A20 is essential for regulating TLR responses in mice; (ii) whether A20 regulates ubiquitylation of critical TLR signaling proteins; and (iii) how A20 recognizes ubiquitylated proteins and may function as both a de-ubiquitylating enzyme and an E3. In the latter approach, mass spectroscopic analysis will be essential for understanding how A20 modifies ubiquitylated proteins. Selected TLR signaling proteins will be examined as putative substrates, and both A20's de-ubiquitylating and ubiquitylating functions will be assessed on candidate substrates. Results from these studies promise to yield significant insights into how A20 links the regulation of ubiquitylation with disease.

这个子项目是众多研究子项目之一